Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Burstein

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
THF-gamma 2-mediated reduction of pulmonary metastases and augmentation of immunocompetence in C57BL/6 mice bearing B16-melanomaR Ophir, G Moalem, M Pecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1982
Recent duplication and germ-line diversification of rat immunoglobulin kappa chain gene joining segmentsY Burstein, A V Breiner, C R Brandt, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
Inhibition of murine Lewis lung carcinoma metastases by combined chemotherapy and intranasal THF-gamma 2 immunotherapyG Rashid, R Ophir, M Pecht, et al.
Immunopharmacology and Immunotoxicology|May 1, 1996
Thymic humoral factor-gamma 2 (THF-gamma 2) immunotherapy reduces the metastatic load and restores immunocompetence in 3LL tumor-bearing mice receiving anticancer chemotherapyR Ophir, M Pecht, Y Keisari, et al.
Experimental Hematology|February 1, 1992
Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growthY Barak, T Hahn, M Pecht, et al.
Cancer|January 5, 2000
Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study reportB Stark, R Sharon, G Rechavi, et al.
Acta Haematologica|January 1, 1991
Bone marrow cell populations mimicking common acute lymphoblastic leukemia in infants with stage IV-S neuroblastomaM Mandel, G Rechavi, Y Neumann, et al.
Harefuah|April 1, 1990
[Israel national childhood acute lymphoblastic leukemia study]B Stark, A Abramov, D Attias, et al.
International Journal of Immunopharmacology|January 1, 1987
Immunoreconstitution of T-cell impairments in asymptomatic male homosexuals by thymic humoral factor (THF)Z T Handzel, Y Berner, O Segal, et al.
Israel Journal of Medical Sciences|May 1, 1986
Treatment of congenital immune deficiencies with a thymic hormone--thymic humoral factorZ T Handzel, Y Elitsur, S Algrimawi, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
THF-gamma 2-mediated reduction of pulmonary metastases and augmentation of immunocompetence in C57BL/6 mice bearing B16-melanomaR Ophir, G Moalem, M Pecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1982
Recent duplication and germ-line diversification of rat immunoglobulin kappa chain gene joining segmentsY Burstein, A V Breiner, C R Brandt, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
Inhibition of murine Lewis lung carcinoma metastases by combined chemotherapy and intranasal THF-gamma 2 immunotherapyG Rashid, R Ophir, M Pecht, et al.
Immunopharmacology and Immunotoxicology|May 1, 1996
Thymic humoral factor-gamma 2 (THF-gamma 2) immunotherapy reduces the metastatic load and restores immunocompetence in 3LL tumor-bearing mice receiving anticancer chemotherapyR Ophir, M Pecht, Y Keisari, et al.
Experimental Hematology|February 1, 1992
Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growthY Barak, T Hahn, M Pecht, et al.
Cancer|January 5, 2000
Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study reportB Stark, R Sharon, G Rechavi, et al.
Acta Haematologica|January 1, 1991
Bone marrow cell populations mimicking common acute lymphoblastic leukemia in infants with stage IV-S neuroblastomaM Mandel, G Rechavi, Y Neumann, et al.
Harefuah|April 1, 1990
[Israel national childhood acute lymphoblastic leukemia study]B Stark, A Abramov, D Attias, et al.
International Journal of Immunopharmacology|January 1, 1987
Immunoreconstitution of T-cell impairments in asymptomatic male homosexuals by thymic humoral factor (THF)Z T Handzel, Y Berner, O Segal, et al.
Israel Journal of Medical Sciences|May 1, 1986
Treatment of congenital immune deficiencies with a thymic hormone--thymic humoral factorZ T Handzel, Y Elitsur, S Algrimawi, et al.
Pageof 13